Rhythm and movement training to support thinking skills in Parkinson's disease
Tests the Ronnie Gardiner Method on thinking skills in adults with Parkinson's disease.
Plain-language title generated from the registry record
Registry title: Short Term Effects of a Multimodal Intervention With RGM on Cognition in People With Parkinson's Disease.
Key facts
- Where
- Ghent, BelgiumSee the site
Where in Belgium
- University Hospital GhentGhent, BelgiumTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Ghent
- Trial code
- NCT07863219
- Record updated
- 7 October 2026
- Original description
The goal of this clinical trial is to learn if the Ronnie Gardiner Method (RGM) works to improve cognitive functions in adults with Parkinson's disease (early to mid-stage). It will also learn about the secondary effects on speech, mobility, balance, and mood.Read full original descriptionShow less
Short-term Effects of an Intervention Consisting of 10 RGM (Ronnie Gardiner Method) Training Sessions on Cognitive Functions in Individuals With Early- to Mid-stage Parkinson's Disease.
The goal of this clinical trial is to learn if the Ronnie Gardiner Method (RGM) works to improve cognitive functions in adults with Parkinson's disease (early to mid-stage). It will also learn about the secondary effects on speech, mobility, balance, and mood.
The main questions it aims to answer are:
* Does a 10-week RGM intervention improve cognitive aspects, speech (indirectly through improved breathing), mobility, and balance in participants with Parkinson's disease? * How do participants experience the intensity, difficulty, and emotional impact of the RGM sessions?
Inclusion: diagnosis of idiopathic Parkinson's disease; safe, independent mobility and participation (Hoehn and Yahr stages 1-3); a stable dopaminergic medication regimen for at least 4 weeks prior to study participation; willingness and ability to participate in a 10-week intervention program; willingness to participate in the study (signing of informed consent).
Exclusion: Presence of other neurological or severe psychiatric conditions that could interfere with participation or the interpretation of results (e.g., substance use disorder, severe depression, psychosis); Severe visual or hearing impairments that limit the ability to follow group instructions as determined by a physician; Physical limitations that inhibit safe participation in moderate-to-vigorous exercise or group rehabilitation.